BioStock: Extended cannabis programme in Denmark gives DanCann Pharma tailwind

Last week, Danish drug developer DanCann Pharma announced that the Danish government has decided to prolong the Pilot Programme with medical cannabis – permanently for the industry and four more years for patients. This is positive for news for DanCann whose brand new and first high-tech cultivation facility, BIOTECH PHARM1, for the cultivation of medical cannabis recently began operating.

Read the article at biostock.se:

https://www.biostock.se/en/extended-cannabis-programme-in-denmark-gives-dancann-pharma-tailwind/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/